Anticancer Effect of Deuterium Depleted Water - Redox Disbalance Leads to Oxidative Stress.


Journal

Molecular & cellular proteomics : MCP
ISSN: 1535-9484
Titre abrégé: Mol Cell Proteomics
Pays: United States
ID NLM: 101125647

Informations de publication

Date de publication:
12 2019
Historique:
received: 01 04 2019
revised: 22 08 2019
pubmed: 15 9 2019
medline: 2 7 2020
entrez: 15 9 2019
Statut: ppublish

Résumé

Despite the convincing empirical evidence that deuterium depleted water (DDW, 25-125 ppm deuterium) has anticancer effect, the molecular mechanism remains unclear. Here, redox proteomics investigation of the DDW action in A549 cells revealed an increased level of oxidative stress, whereas expression proteomics in combination with thermal profiling uncovered crucial role of mitochondrial proteins. In the proposed scenario, reversal of the normally positive deuterium gradient across the inner membrane leads to an increased export of protons from the matrix to intermembrane space and an increase in the mitochondrial membrane potential, enhancing the production of reactive oxygen species (ROS). The resulting oxidative stress leads to slower growth and can induce apoptosis. However, further deuterium depletion in ambient water triggers a feedback mechanism, which leads to restoration of the redox equilibrium and resumed growth. The DDW-induced oxidative stress, verified by traditional biochemical assays, may be helpful as an adjuvant to ROS-inducing anticancer therapy.

Identifiants

pubmed: 31519768
pii: S1535-9476(20)31643-1
doi: 10.1074/mcp.RA119.001455
pmc: PMC6885702
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Proteome 0
Reactive Oxygen Species 0
Water 059QF0KO0R
Deuterium AR09D82C7G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2373-2387

Informations de copyright

© 2019 Zhang et al.

Références

Nat Protoc. 2015 Oct;10(10):1567-93
pubmed: 26379230
Asian Pac J Cancer Prev. 2014;15(5):2179-83
pubmed: 24716953
Biomed Pharmacother. 2013 Jul;67(6):489-96
pubmed: 23773852
Cell Death Differ. 2018 Jan;25(1):93-103
pubmed: 29099489
Jpn J Cancer Res. 1990 Jan;81(1):85-90
pubmed: 2108951
Expert Opin Ther Targets. 2012 Jan;16(1):67-83
pubmed: 22239435
Am J Epidemiol. 2002 Aug 1;156(3):274-85
pubmed: 12142263
Gene. 2000 May 2;248(1-2):109-16
pubmed: 10806356
Exp Ther Med. 2010 Mar;1(2):277-283
pubmed: 22993540
J Proteome Res. 2016 Aug 5;15(8):2548-59
pubmed: 27350002
Bull Exp Biol Med. 2006 Nov;142(5):570-2
pubmed: 17415464
Adv Cancer Res. 2014;122:1-67
pubmed: 24974178
Nutr Cancer. 2013;65(2):240-6
pubmed: 23441611
FEBS Lett. 1993 Feb 8;317(1-2):1-4
pubmed: 8428617
Nat Rev Neurosci. 2005 Nov;6(11):829-40
pubmed: 16224498
Nat Rev Mol Cell Biol. 2005 Jan;6(1):44-55
pubmed: 15688066
Immunol Today. 1994 Jan;15(1):7-10
pubmed: 8136014
Cell. 2014 Jan 16;156(1-2):317-331
pubmed: 24439385
Mol Cell. 2012 Sep 14;47(5):767-76
pubmed: 22819323
Nat Commun. 2018 Jan 22;9(1):324
pubmed: 29358734
Oncotarget. 2017 May 30;8(22):35728-35742
pubmed: 28415723
J Biol Chem. 1980 Apr 10;255(7):3057-61
pubmed: 6766943
Cell Death Differ. 2006 Jun;13(6):994-1002
pubmed: 16543937
Acta Crystallogr D Biol Crystallogr. 2004 Apr;60(Pt 4):646-55
pubmed: 15039552
Mutat Res. 1988 Sep;201(1):195-201
pubmed: 3419447
Integr Cancer Ther. 2008 Sep;7(3):172-81
pubmed: 18815148
Nat Rev Cancer. 2018 Feb;18(2):89-102
pubmed: 29242642
J Mol Biol. 2012 Jul 13;420(3):176-89
pubmed: 22516612
Science. 2014 Oct 3;346(6205):1255784
pubmed: 25278616
In Vivo. 2000 May-Jun;14(3):437-9
pubmed: 10904878
PLoS One. 2014 Jul 17;9(7):e102071
pubmed: 25033078
J Proteome Res. 2017 Feb 3;16(2):689-697
pubmed: 27973853
Oncol Rep. 2016 Jan;35(1):546-51
pubmed: 26530353
DNA Cell Biol. 2013 May;32(5):220-7
pubmed: 23530606
Cell Death Discov. 2016 Oct 03;2:16068
pubmed: 27752363
Nat Rev Cancer. 2009 Oct;9(10):691-700
pubmed: 19759539
Sci Rep. 2015 Jun 08;5:11176
pubmed: 26052917
Dokl Biochem Biophys. 2017 Sep;476(1):323-325
pubmed: 29101745
Med Hypotheses. 2016 Feb;87:69-74
pubmed: 26826644
Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
pubmed: 20840865
Cell Death Differ. 2018 Jan;25(1):114-132
pubmed: 29125603
Free Radic Biol Med. 2012 Aug 1;53(3):488-97
pubmed: 22634395
Iran Biomed J. 2018 Sep 17;23(2):129-41
pubmed: 30220191
Am J Physiol. 1989 Oct;257(4 Pt 1):L163-73
pubmed: 2572174
Cell Death Differ. 2000 Oct;7(10):868-79
pubmed: 11279532
Science. 1998 Jun 5;280(5369):1576-80
pubmed: 9616115
Nat Rev Cancer. 2014 May;14(5):359-70
pubmed: 24739573
Sci Rep. 2017 May 8;7(1):1590
pubmed: 28484215
Cell Death Differ. 2013 Jul;20(7):888-97
pubmed: 23449391
Cell Death Differ. 2002 Mar;9(3):252-63
pubmed: 11859408
Cell Tissue Kinet. 1976 Jul;9(4):333-40
pubmed: 945129
Proc Natl Acad Sci U S A. 2008 Jun 17;105(24):8197-202
pubmed: 18287020

Auteurs

Xuepei Zhang (X)

Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 165 Stockholm, Sweden.

Massimiliano Gaetani (M)

Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 165 Stockholm, Sweden.

Alexey Chernobrovkin (A)

Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 165 Stockholm, Sweden.

Roman A Zubarev (RA)

Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, SE-17 165 Stockholm, Sweden. Electronic address: Roman.Zubarev@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH